Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications

MLA

Bryan T. Kelly, et al. “Outcomes for Hospitalized Patients with Idiopathic Pulmonary Fibrosis Treated with Antifibrotic Medications.” BMC Pulmonary Medicine, vol. 21, no. 1, July 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12890-021-01607-2.

APA

Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, & Andrew H. Limper. (2021). Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications. BMC Pulmonary Medicine, 21(1), 1–14. https://doi.org/10.1186/s12890-021-01607-2

Chicago

Bryan T. Kelly, Viengneesee Thao, Timothy M. Dempsey, Lindsey R. Sangaralingham, Stephanie R. Payne, Taylor T. Teague, Teng Moua, Nilay D. Shah, and Andrew H. Limper. 2021. “Outcomes for Hospitalized Patients with Idiopathic Pulmonary Fibrosis Treated with Antifibrotic Medications.” BMC Pulmonary Medicine 21 (1): 1–14. doi:10.1186/s12890-021-01607-2.